The trailer of Vir Das’ directorial debut, Happy Patel Khatarnak Jasoos was unveiled by the makers on Friday, December 19, 2025. Written by Vir and Amogh Randive, the film has been directed by Vir ...
Vir Das is all set to return to the big screen with his first Hindi film as a director, Happy Patel. The film is directed by Kavi Shastri. The trailer for this comedy film opens with Vir Das ...
Vir Biotechnology ( (VIR)) just unveiled an update. On December 16, 2025, Vir Biotechnology entered into a license agreement with Norgine Pharma UK Limited, granting Norgine exclusive commercial ...
Many racetracks have succumbed to high real-estate prices in recent years, their sweeping turns or steep banking replaced by subdivisions or warehouses. At least for now, Virginia International ...
Investing.com - Leerink Partners reiterated an Outperform rating and $16.00 price target on Vir Biotechnology (NASDAQ:VIR) following Mirum’s acquisition of private company Bluejay. VIR shares, ...
Actor-comedian Vir Das is set to make his directorial debut with an upcoming spy-comedy film, Happy Patel: Khatarnak Jasoos, backed by Aamir Khan Productions. The banner made the announcement by ...
An announcement video for Happy Patel: Khatarnak Jasoos was released on Wednesday, which sees producer Aamir Khan beating up Vir Das for making a ‘flop’ spy film in his directorial debut. The ...
Vir Biotechnology Inc (NASDAQ:VIR) completed enrollment in Eclipse One, their first registrational phase 3 study for hepatitis Delta, ahead of schedule. The company plans to share a comprehensive data ...
– Phase 1 clinical trial designed to assess the safety, pharmacokinetics and preliminary efficacy of VIR-5500 in combination with androgen receptor pathway inhibitors in first-line mCRPC – Clinical ...
Vir Biotechnology, Inc. (NASDAQ:VIR), currently trading at $5.02, has seen its stock decline over 34% year-to-date, reflecting investor concerns despite its potential in treating serious infectious ...
Hosted on MSN
B of A Securities Upgrades Vir Biotechnology (VIR)
Fintel reports that on August 27, 2025, B of A Securities upgraded their outlook for Vir Biotechnology (NasdaqGS:VIR) from Neutral to Buy. Analyst Price Forecast Suggests 243.74% Upside As of August ...
As festivities for Independence Day begin, the centre on Thursday awarded Vir Chakra to nine Indian Air Force officers for their brave contributions in the service of the nation during Operation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results